An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Giapreza

Chemical Nameangiotensin II
Dosage FormInjection (intravenous; 2.5 mg/mL, 5 mg/2 mL)
Drug ClassHormones
SystemCardiovascular
CompanyLa Jolla Pharmaceuticals
Approval Year2017

Indication

  • To increase blood pressure in adults with septic or other distributive shock.
Last updated on 11/1/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Giapreza (angiotensin II) Prescribing Information2017La Jolla Pharmaceutical Company, San Diego, CA
Document TitleYearSource
Novel vasopressors in the treatment of vasodilatory shock: a systematic review of angiotensin II, selepressin, and terlipressin. 2018Journal of Intensive Care Medicine